Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout
© 2022 American College of Rheumatology..
OBJECTIVE: To determine whether a gout polygenic risk score (PRS) is associated with age at gout onset and tophaceous disease in European, East Polynesian, and West Polynesian men and women with gout.
METHODS: A 19-variant gout PRS was produced in 7 European gout cohorts (N = 4,016), 2 East Polynesian gout cohorts (N = 682), and 1 West Polynesian gout cohort (N = 490). Sex-stratified regression models were used to estimate the relationship between the PRS and age at gout onset and tophaceous disease.
RESULTS: The PRS was associated with earlier age at gout onset in men (β = -3.61 in years per unit PRS [95% confidence interval (95% CI) -4.32, -2.90] in European men; β = -6.35 [95% CI -8.91, -3.80] in East Polynesian men; β = -3.51 [95% CI -5.46, -1.57] in West Polynesian men) but not in women (β = 0.07 [95% CI -2.32, 2.45] in European women; β = 0.20 [95% CI -7.21, 7.62] in East Polynesian women; β -3.33 [95% CI -9.28, 2.62] in West Polynesian women). The PRS showed a positive association with tophaceous disease in men (odds ratio [OR] for the association 1.15 [95% CI 1.00, 1.31] in European men; OR 2.60 [95% CI 1.66, 4.06] in East Polynesian men; OR 1.53 [95% CI 1.07, 2.19] in West Polynesian men) but not in women (OR for the association 0.68 [95% CI 0.42, 1.10] in European women; OR 1.45 [95% CI 0.39, 5.36] in East Polynesian women). The PRS association with age at gout onset was robust to the removal of ABCG2 variants from the PRS in European and East Polynesian men (β = -2.42 [95% CI -3.37, -1.46] and β = -6.80 [95% CI -10.06, -3.55], respectively) but not in West Polynesian men (β = -1.79 [95% CI -4.74, 1.16]).
CONCLUSION: Genetic risk variants for gout also harbor risk for earlier age at gout onset and tophaceous disease in European and Polynesian men. Our findings suggest that earlier gout onset involves the accumulation of gout risk alleles in men but perhaps not in women, and that this genetic risk is shared across multiple ancestral groups.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:75 |
|---|---|
| Enthalten in: |
Arthritis & rheumatology (Hoboken, N.J.) - 75(2023), 5 vom: 16. Mai, Seite 816-825 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 17.05.2023 Date Revised 22.05.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1002/art.42393 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347963013 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347963013 | ||
| 003 | DE-627 | ||
| 005 | 20231226035055.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/art.42393 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1159.xml |
| 035 | |a (DE-627)NLM347963013 | ||
| 035 | |a (NLM)36281732 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sumpter, Nicholas A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.05.2023 | ||
| 500 | |a Date Revised 22.05.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 American College of Rheumatology. | ||
| 520 | |a OBJECTIVE: To determine whether a gout polygenic risk score (PRS) is associated with age at gout onset and tophaceous disease in European, East Polynesian, and West Polynesian men and women with gout | ||
| 520 | |a METHODS: A 19-variant gout PRS was produced in 7 European gout cohorts (N = 4,016), 2 East Polynesian gout cohorts (N = 682), and 1 West Polynesian gout cohort (N = 490). Sex-stratified regression models were used to estimate the relationship between the PRS and age at gout onset and tophaceous disease | ||
| 520 | |a RESULTS: The PRS was associated with earlier age at gout onset in men (β = -3.61 in years per unit PRS [95% confidence interval (95% CI) -4.32, -2.90] in European men; β = -6.35 [95% CI -8.91, -3.80] in East Polynesian men; β = -3.51 [95% CI -5.46, -1.57] in West Polynesian men) but not in women (β = 0.07 [95% CI -2.32, 2.45] in European women; β = 0.20 [95% CI -7.21, 7.62] in East Polynesian women; β -3.33 [95% CI -9.28, 2.62] in West Polynesian women). The PRS showed a positive association with tophaceous disease in men (odds ratio [OR] for the association 1.15 [95% CI 1.00, 1.31] in European men; OR 2.60 [95% CI 1.66, 4.06] in East Polynesian men; OR 1.53 [95% CI 1.07, 2.19] in West Polynesian men) but not in women (OR for the association 0.68 [95% CI 0.42, 1.10] in European women; OR 1.45 [95% CI 0.39, 5.36] in East Polynesian women). The PRS association with age at gout onset was robust to the removal of ABCG2 variants from the PRS in European and East Polynesian men (β = -2.42 [95% CI -3.37, -1.46] and β = -6.80 [95% CI -10.06, -3.55], respectively) but not in West Polynesian men (β = -1.79 [95% CI -4.74, 1.16]) | ||
| 520 | |a CONCLUSION: Genetic risk variants for gout also harbor risk for earlier age at gout onset and tophaceous disease in European and Polynesian men. Our findings suggest that earlier gout onset involves the accumulation of gout risk alleles in men but perhaps not in women, and that this genetic risk is shared across multiple ancestral groups | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 700 | 1 | |a Takei, Riku |e verfasserin |4 aut | |
| 700 | 1 | |a Cadzow, Murray |e verfasserin |4 aut | |
| 700 | 1 | |a Topless, Ruth K G |e verfasserin |4 aut | |
| 700 | 1 | |a Phipps-Green, Amanda J |e verfasserin |4 aut | |
| 700 | 1 | |a Murphy, Rinki |e verfasserin |4 aut | |
| 700 | 1 | |a de Zoysa, Janak |e verfasserin |4 aut | |
| 700 | 1 | |a Watson, Huti |e verfasserin |4 aut | |
| 700 | 1 | |a Qasim, Muhammad |e verfasserin |4 aut | |
| 700 | 1 | |a Lupi, Alexa S |e verfasserin |4 aut | |
| 700 | 1 | |a Abhishek, Abhishek |e verfasserin |4 aut | |
| 700 | 1 | |a Andrés, Mariano |e verfasserin |4 aut | |
| 700 | 1 | |a Crișan, Tania O |e verfasserin |4 aut | |
| 700 | 1 | |a Doherty, Michael |e verfasserin |4 aut | |
| 700 | 1 | |a Jacobsson, Lennart |e verfasserin |4 aut | |
| 700 | 1 | |a Janssen, Matthijs |e verfasserin |4 aut | |
| 700 | 1 | |a Jansen, Tim L |e verfasserin |4 aut | |
| 700 | 1 | |a Joosten, Leo A B |e verfasserin |4 aut | |
| 700 | 1 | |a Kapetanovic, Meliha |e verfasserin |4 aut | |
| 700 | 1 | |a Lioté, Frédéric |e verfasserin |4 aut | |
| 700 | 1 | |a Matsuo, Hirotaka |e verfasserin |4 aut | |
| 700 | 1 | |a McCarthy, Geraldine M |e verfasserin |4 aut | |
| 700 | 1 | |a Perez-Ruiz, Fernando |e verfasserin |4 aut | |
| 700 | 1 | |a Riches, Philip |e verfasserin |4 aut | |
| 700 | 1 | |a Richette, Pascal |e verfasserin |4 aut | |
| 700 | 1 | |a Roddy, Edward |e verfasserin |4 aut | |
| 700 | 1 | |a Stiburkova, Blanka |e verfasserin |4 aut | |
| 700 | 1 | |a So, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Tausche, Anne-Kathrin |e verfasserin |4 aut | |
| 700 | 1 | |a Torres, Rosa J |e verfasserin |4 aut | |
| 700 | 1 | |a Uhlig, Till |e verfasserin |4 aut | |
| 700 | 1 | |a Major, Tanya J |e verfasserin |4 aut | |
| 700 | 1 | |a Stamp, Lisa K |e verfasserin |4 aut | |
| 700 | 1 | |a Dalbeth, Nicola |e verfasserin |4 aut | |
| 700 | 1 | |a Choi, Hyon K |e verfasserin |4 aut | |
| 700 | 1 | |a Vazquez, Ana I |e verfasserin |4 aut | |
| 700 | 1 | |a Leask, Megan P |e verfasserin |4 aut | |
| 700 | 1 | |a Reynolds, Richard J |e verfasserin |4 aut | |
| 700 | 1 | |a Merriman, Tony R |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Arthritis & rheumatology (Hoboken, N.J.) |d 2014 |g 75(2023), 5 vom: 16. Mai, Seite 816-825 |w (DE-627)NLM234543671 |x 2326-5205 |7 nnns |
| 773 | 1 | 8 | |g volume:75 |g year:2023 |g number:5 |g day:16 |g month:05 |g pages:816-825 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/art.42393 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 75 |j 2023 |e 5 |b 16 |c 05 |h 816-825 | ||